Persevere Therapeutics Inc. — Form D

Persevere Therapeutics Inc. of CHESTERBROOK, PA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-04. The offering totals $5.0M, of which $1.6M was reported sold. Industry: Other.

Offering

• Filed: 2026-03-04
• Form: D
• Accession: 0002115419-26-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $1.6M
• Remaining: $3.4M
• Investors: 12
• Date of first sale: 2026-02-11
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-575357

Issuer

• Name: Persevere Therapeutics Inc.
• CIK: 0002115419
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 851 DUPORTAIL ROAD, 2ND FLOOR, CHESTERBROOK, PA, 19087
• Phone: 610.780.0622

Officers, directors & promoters (2)

More

• CIK 2115419 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search